Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis
Authors
Keywords
-
Journal
Current Osteoporosis Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-11
DOI
10.1007/s11914-019-00545-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in the osteocyte lacunocanalicular network with aging
- (2019) LeAnn M. Tiede-Lewis et al. BONE
- The regulation and importance of monocyte chemoattractant protein-1
- (2018) Vanessa Bianconi et al. CURRENT OPINION IN HEMATOLOGY
- A guide to chemokines and their receptors
- (2018) Catherine E. Hughes et al. FEBS Journal
- Associations between the chemokine biomarker CCL2 and knee osteoarthritis outcomes: the Johnston County Osteoarthritis Project
- (2018) L. Longobardi et al. OSTEOARTHRITIS AND CARTILAGE
- CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis
- (2018) Dabin Lee et al. Cell Death & Disease
- The effect of mesenchymal stem cells on chemotaxis of osteoclast precursor cells
- (2018) Keisuke Sumi et al. Journal of Oral Science
- The bone remodelling cycle
- (2018) JS Kenkre et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Parathyroid hormone(1–34) and its analogs differentially modulate osteoblastic Rankl expression via PKA/SIK2/SIK3 and PP1/PP2A–CRTC3 signaling
- (2018) Florante R. Ricarte et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells Through SRC and PKC Activation
- (2018) Min Yao et al. MOLECULAR CANCER RESEARCH
- Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
- (2017) Andrew S. Gdowski et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis
- (2017) Bradley L. Young et al. JOURNAL OF RHEUMATOLOGY
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- The HIV co-receptor CCR5 regulates osteoclast function
- (2017) Ji-Won Lee et al. Nature Communications
- Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma
- (2017) Lin Yan et al. Oncotarget
- CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
- (2017) Jawed Akhtar Siddiqui et al. Frontiers in Endocrinology
- Bone Cancer
- (2017) J. Sybil Biermann et al. Journal of the National Comprehensive Cancer Network
- The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
- (2017) Patricia Macanas-Pirard et al. PLoS One
- Catabolic Effects of Human PTH (1–34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism
- (2017) Jawed A. Siddiqui et al. Scientific Reports
- Inflammation, fracture and bone repair
- (2016) Florence Loi et al. BONE
- Adipose, Bone, and Myeloma: Contributions from the Microenvironment
- (2016) Michelle M. McDonald et al. CALCIFIED TISSUE INTERNATIONAL
- Endo180 at the cutting edge of bone cancer treatment and beyond
- (2016) Justin Sturge JOURNAL OF PATHOLOGY
- Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
- (2016) Roni Allaoui et al. Nature Communications
- Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo
- (2016) Laura E. Wright et al. Oncotarget
- Targeting the CCL2-CCR2 signaling axis in cancer metastasis
- (2016) Su Yin Lim et al. Oncotarget
- Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding
- (2016) Marko Roblek et al. NEOPLASIA
- Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivo
- (2015) Xinyi Jiang et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity
- (2015) Yusuke Ito et al. PROSTATE
- MEK inhibitor diminishes nasopharyngeal carcinoma (NPC) cell growth and NPC-induced osteoclastogenesis via modulating CCL2 and CXCL16 expressions
- (2015) Yu Zhu et al. TUMOR BIOLOGY
- Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases
- (2015) Dulshara Sachini Amarasekara et al. Journal of Immunology Research
- Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo
- (2014) P. D. Ottewell et al. CLINICAL CANCER RESEARCH
- Serum Monocyte Chemokine Protein-1 Levels Before and After Parathyroidectomy in Patients with Primary Hyperparathyroidism
- (2014) Hemal Patel et al. Endocrine Practice
- MCP-1 as a Potential Target to Inhibit the Bone Invasion by Oral Squamous Cell Carcinoma
- (2014) Jingjing Quan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
- (2014) Laura Bonapace et al. NATURE
- Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation
- (2014) Dirk Woetzel et al. ARTHRITIS RESEARCH & THERAPY
- MCP-1 Expression Is Specifically Regulated During Activation of Skeletal Repair and Remodeling
- (2013) A. C. Wu et al. CALCIFIED TISSUE INTERNATIONAL
- Association of systemic and intra-articular osteoclastogenic potential, pro-inflammatory mediators and disease activity with the form of inflammatory arthritis
- (2013) Marina Ikić et al. INTERNATIONAL ORTHOPAEDICS
- Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone
- (2013) Joseph A Tamasi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Dominant Negative MCP-1 Blocks Human Osteoclast Differentiation
- (2013) Nigel A. Morrison et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Circulating Fibrocytes Prepare the Lung for Cancer Metastasis by Recruiting Ly-6C+ Monocytes Via CCL2
- (2013) H. W. van Deventer et al. JOURNAL OF IMMUNOLOGY
- The metastatic niche and stromal progression
- (2012) Jonathan P. Sleeman CANCER AND METASTASIS REVIEWS
- Bone as an Endocrine Organ
- (2012) Anyonya Guntur et al. Endocrine Practice
- Inflammatory bone loss: pathogenesis and therapeutic intervention
- (2012) Kurt Redlich et al. NATURE REVIEWS DRUG DISCOVERY
- Disorders of Bone Remodeling
- (2011) Xu Feng et al. Annual Review of Pathology-Mechanisms of Disease
- The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
- (2011) Robert R. Langley et al. INTERNATIONAL JOURNAL OF CANCER
- Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation
- (2011) Ok-Joo Sul et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
- (2009) Xin Li et al. CANCER RESEARCH
- Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model
- (2009) Munehisa Takahashi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
- (2009) Satish L. Deshmane et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis
- (2009) Nikolaus B Binder et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started